Curran Simpson, SVP, Product Development & CTO at REGENXBIO Inc. (RGNX), sold 31,104 shares at $44.26 ($1.4M) on 2019-12-09, disclosed to the SEC on 2019-12-11.
Open-market sale of $1.4M RGNX by SVP, Product Development & CTO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $43.40 | 9,399 | $408K | 30.0% |
| 2 | $43.40 | 9,399 | $408K | 30.0% |
| 3 | $44.26 | 6,153 | $272K | 20.0% |
| 4 | $44.26 | 6,153 | $272K | 20.0% |
| Total | $43.74 avg | 31,104 | $1.4M | 100% |
| Filing → |
| RGNX | SELL | 2025-09-12 | $155K | — | Filing → |
| RGNX | SELL | 2024-08-05 | $2K | — | Filing → |
| RGNX | SELL | 2024-07-30 | $290K | — | Filing → |